First person – Tigist Tamir

Abstract

ABSTRACT First Person is a series of interviews with the first authors of a selection of papers published in Journal of Cell Science, helping early-career researchers promote themselves alongside their papers. Tigist Tamir is first author on ‘Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor’, published in JCS. Tigist conducted the research described in this article while a graduate student in Michael Ben Major's lab at Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, USA. They are now a postdoctoral associate in the lab of Forest White at Koch Institute for Integrated Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, where they are interested in integrating cutting edge ‘omics’ technologies to better elucidate drivers of cancer progression and therapy resistance.